The Fifth Annual Nordic-American Life Science Conference presents the best in Nordic BioPharma and MedTech to US investors and the life science industry.
Join life science and banking experts and distinguished partners to learn about advances in oncology, rare diseases, neurology, diagnostic imaging, and many other therapeutic areas in this three-part virtual event.
The NALS Conference brings together OxThera, Immedica, Oncoinvent, SonoClear, Sobi, Oncopeptides, Ossur, Novo Nordisk, Johnston & Johnson, Ambu, Lundbeckfonden Ventures, and many more.
Boston’s Back Bay Life Science Advisors, with DNB, Nasdaq, and Business Sweden, is pleased to bring together dozens of high-caliber private and publicly-listed Nordic healthcare companies to nurture robust, cross-border life sciences development.
Registration is complimentary for qualified BD and investors.
See the NALS Conference Program and save your seat at:
www.nordic-americanlifescience.com/
Emerging MedTech Day – November 12, 2020
Global Markets Day – December 3, 2020
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
